Evidence of efficacy, safety & consistent manufacturing are 3 requirements that @Pfizer must demonstrate to seek Emergency Use Authorization for its potential #COVID19 vaccine. Learn more about these key areas: #PFEColleague bit.ly/3n5YnzC